{"id":175642,"name":"THE CAMPAIGN FOR SUSTAINABLE RX PRICING","slug":"the-campaign-for-sustainable-rx-pricing","state":"DC","country":"United States of America","description":"A coalition of organizations working on market-based solutions to drug pricing.","totalSpending":2610000,"filings":33,"yearlySpending":[{"year":2018,"income":320000},{"year":2019,"income":320000},{"year":2020,"income":520000},{"year":2021,"income":440000},{"year":2022,"income":220000},{"year":2023,"income":200000},{"year":2024,"income":230000},{"year":2025,"income":360000}],"issues":["HCR","MMM","PHA","BUD","CPT","TRD"],"firms":["MEHLMAN CONSULTING, INC."],"lobbyists":["BRUCE MEHLMAN","DAVID CASTAGNETTI","DEAN ROSEN","CONSTANTINE HINGSON","DAVID THOMAS","ELISE FINLEY PICKERING","SOHINI GUPTA","SAGE EASTMAN","LAUREN ARONSON","MICHAEL ROBINSON","MICHAEL COLLINS","STEVE HARO","HELEN TOLAR","NICHOLE DISTEFANO","MCKENZIE BRICE","PAUL THORNELL","STEPHEN COTE","ALEXANDER PERKINS","VICTORIA FLOOD","ROSEMARY GUTIERREZ","ZACHARY MALLOVE","CAITLIN VAN SANT","LISA GOLDMAN","ALYENE MLINAR","ERICA CHABOT","ANNIE WOLF","NAVEEN PARMAR","JON ADAME","JOSEPH BROWN","EARL FLOOD"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office","Centers For Medicare and Medicaid Services (CMS)","Executive Office of the President (EOP)","Food & Drug Administration (FDA)","Patent & Trademark Office (PTO)"],"sampleDescriptions":["Prescription drug pricing.\nS. 974 - CREATES Act.\nS. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act\nH.R. 2051 - FAST Generics Act of 2017.\nMedicare Part D Biosimilars","Prescription drug pricing.\nMedicare Part D Biosimilars.\nH.R. 1892 - The Bipartisan Budget Act of 2018, Omnibus","Prescription drug pricing.\nS. 974 - CREATES Act.\nS. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act\nH.R. 2051 - FAST Generics Act of 2017\nMedicare Part D Biosimilars.","H.R. 1892 - The Bipartisan Budget Act of 2018, Omnibus","Prescription drug pricing.\nS. 974 - CREATES Act.\nS. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act\nH.R. 2051 - FAST Generics Act of 2017.\nMedicare Part D Biosimilars"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}